| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | R$ 11.45B | R$ 10.15B | R$ 8.66B | R$ 7.82B | R$ 6.41B |
| Gross Profit | R$ 1.75B | R$ 1.52B | R$ 1.29B | R$ 1.15B | R$ 907.57M |
| Operating Income | R$ 381.63M | R$ 254.34M | R$ 245.62M | R$ 228.68M | R$ 100.39M |
| EBITDA | R$ 581.79M | R$ 401.46M | R$ 353.37M | R$ 380.44M | R$ 226.44M |
| Net Income | R$ 118.90M | R$ 114.58M | R$ 70.40M | R$ 80.87M | R$ 78.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | R$ 235.12M | R$ 229.55M | R$ 193.74M | R$ 183.25M | R$ 188.52M |
| Total Assets | R$ 6.23B | R$ 5.62B | R$ 4.94B | R$ 4.36B | R$ 4.03B |
| Total Debt | R$ 1.40B | R$ 1.25B | R$ 1.14B | R$ 1.02B | R$ 946.88M |
| Net Debt | R$ 1.17B | R$ 1.02B | R$ 949.96M | R$ 840.94M | R$ 758.37M |
| Total Liabilities | R$ 4.60B | R$ 4.03B | R$ 3.40B | R$ 2.85B | R$ 2.56B |
| Stockholders' Equity | R$ 1.35B | R$ 1.30B | R$ 1.25B | R$ 1.19B | R$ 1.09B |
| Cash Flow | |||||
| Free Cash Flow | R$ 190.15M | R$ 469.03M | R$ 246.89M | R$ 115.81M | R$ 94.03M |
| Operating Cash Flow | R$ 336.89M | R$ 497.09M | R$ 260.90M | R$ 126.32M | R$ 107.58M |
| Investing Cash Flow | R$ -176.14M | R$ -136.84M | R$ -96.58M | R$ -21.74M | R$ -86.41M |
| Financing Cash Flow | R$ -155.18M | R$ -324.44M | R$ -153.83M | R$ -109.84M | R$ -204.44M |
Profarma Distribuidora de Produtos Farmaceuticos SA (BR:PFRM3)
:PFRM3
